KETALAR Injection 200mg/20mL – Ketamine HCl Vial

KETALAR Injection 200mg/20mL contains ketamine hydrochloride at a concentration of 10 mg/mL. Each 20 mL vial contains a total of 200 mg of ketamine. KETALAR serves as a prescription anesthetic and requires administration by qualified healthcare professionals.

Product Overview

KETALAR contains ketamine hydrochloride, an established pharmaceutical anesthetic. Healthcare professionals use ketamine in appropriate clinical settings when they need its anesthetic properties.

This presentation offers a clearly defined 10 mg/mL concentration in a 20 mL vial. As a result, healthcare professionals can easily identify the product strength and total volume when reviewing their medication inventory.

The product comes as a sterile injectable solution. Medical professionals should follow the official prescribing information when they select, prepare, store, and administer KETALAR.

KETALAR 200mg/20mL Specifications

• Product: KETALAR Injection
• Active ingredient: Ketamine hydrochloride
• Strength: 10 mg/mL
• Total content: 200 mg per 20 mL
• Vial volume: 20 mL
• Dosage form: Injectable solution
• Classification: Prescription medication and controlled substance

The KETALAR 200mg/20mL vial provides a specific concentration for professional clinical use. However, healthcare professionals must determine the appropriate administration method and dosage according to the patient’s circumstances and the official prescribing information.

Clinical Uses

KETALAR carries FDA approval as an anesthetic medication. Healthcare professionals use it within appropriate medical settings according to its approved labeling.

Importantly, traditional ketamine differs from esketamine. The FDA has approved esketamine for specific psychiatric indications, while traditional ketamine does not carry FDA approval specifically for treating depression or other psychiatric disorders.

In some circumstances, clinicians may consider medications for uses outside their FDA-approved indications. Such decisions require professional medical judgment, appropriate patient evaluation, and consideration of applicable regulations.

Professional Handling and Storage

Because KETALAR contains a controlled substance, healthcare facilities must follow applicable requirements for storage, handling, documentation, and administration.

Furthermore, healthcare professionals should consult the current prescribing information for detailed storage conditions and handling instructions. Proper procedures help maintain product quality and support safe clinical practice.

Patients should never attempt to administer prescription ketamine independently. Instead, a qualified healthcare professional should determine whether KETALAR suits the patient’s medical needs.

Safety Information

Ketamine can produce significant effects on the central nervous system. For example, patients may experience sedation, dissociation, dizziness, nausea, changes in blood pressure, or impaired coordination.

Therefore, trained healthcare professionals should monitor patients appropriately during clinical use. Medical teams should also consider relevant medical history, current medications, contraindications, and potential interactions before treatment.

In addition, patients should provide their healthcare professional with complete and accurate information about their medications and medical conditions.

Why Choose the 200mg/20mL Presentation?

The KETALAR Injection 200mg/20mL presentation offers a clearly identified 10 mg/mL concentration in a 20 mL vial. This straightforward specification helps healthcare professionals distinguish the product from other ketamine concentrations.

Moreover, accurate product information supports proper medication identification and inventory management. Healthcare facilities can review the strength, volume, active ingredient, and prescribing information before use.

For healthcare professionals researching KETALAR injection strengths, understanding the available concentrations remains important because different presentations contain different amounts of ketamine.

KETALAR and Ketamine Therapy

People often search for ketamine therapy, ketamine infusion therapy, and ketamine for depression when researching ketamine-based treatments. However, KETALAR’s FDA-approved indication remains anesthesia.

Consequently, patients should not assume that an injectable KETALAR product represents an FDA-approved depression treatment. Anyone considering ketamine for a psychiatric condition should first discuss the treatment with a qualified healthcare professional.

A medical provider can explain the differences between traditional ketamine and FDA-approved esketamine, including potential benefits, risks, alternatives, and regulatory considerations.

Important Product Information

KETALAR is a prescription controlled substance. Only qualified healthcare professionals should prescribe, handle, and administer the medication according to applicable laws and professional standards.

Before using any prescription medication, review the current prescribing information. Also, speak with a qualified medical professional about whether the treatment is appropriate for your specific circumstances.

This page provides general educational information about KETALAR Injection 200mg/20mL. It does not replace professional medical advice, a prescription, or individualized treatment guidance.